When should clonidine be given based on the Clinical Opiate Withdrawal Scale (COWS) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Give Clonidine Based on COWS Score

Clonidine should be given to patients with moderate to severe opioid withdrawal (COWS ≥ 8) when buprenorphine is not available or contraindicated, though buprenorphine is the superior first-line treatment for withdrawal symptoms. 1

Treatment Algorithm Based on COWS Score

COWS < 8 (Mild or Less Withdrawal)

  • No pharmacologic treatment is indicated 1
  • Reassess patient and COWS in 1-2 hours 1
  • Consider supportive care only

COWS ≥ 8 (Moderate to Severe Withdrawal)

  • First-line: Buprenorphine 4-8 mg sublingual based on withdrawal severity 1
  • Alternative: Clonidine when buprenorphine is unavailable or patient is not appropriate for buprenorphine initiation 1

Clonidine Dosing for Opioid Withdrawal

When clonidine is selected as the treatment agent:

  • Initial dose: 0.1 mg twice daily (morning and bedtime) 2
  • May increase by 0.1 mg per day at weekly intervals if necessary 2
  • Single ED dose: 0.3 mg oral has been studied for acute withdrawal 3
  • Monitor blood pressure carefully, as hypotension is a known adverse effect 3

Critical Evidence Hierarchy

Buprenorphine is definitively superior to clonidine for opioid withdrawal treatment across multiple outcomes 1, 4:

  • Patients receiving buprenorphine had less severe withdrawal symptoms compared to clonidine 1
  • Buprenorphine resulted in fewer adverse effects and longer treatment retention 1
  • Medication type (buprenorphine vs clonidine) was the single best predictor of treatment success regardless of setting 4

Important Clinical Caveats

When Clonidine May Be Preferred

  • Patient is not yet in sufficient withdrawal to safely initiate buprenorphine (risk of precipitated withdrawal) 1
  • Buprenorphine is unavailable or provider lacks X-waiver for prescribing 1
  • Patient preference or contraindication to opioid agonist therapy 1

Clonidine Safety Concerns

  • Hypotension is a significant risk, particularly in the ED setting 3
  • Abrupt discontinuation can cause rebound hypertension and withdrawal symptoms 2
  • Less effective than buprenorphine at relieving early withdrawal symptoms 4
  • In one comparative study, 63% of clonidine patients required rescue medication within 1 hour versus 27% with olanzapine 3

Adjunctive Medications

Regardless of whether clonidine or buprenorphine is used, consider adding 1:

  • Antiemetics (promethazine, ondansetron) for nausea/vomiting 1, 5
  • Benzodiazepines for anxiety and muscle cramps 1
  • Loperamide for diarrhea 1
  • NSAIDs (ibuprofen) for pain 5

Practical ED Application

The COWS score of 8 serves as the threshold for initiating pharmacologic treatment, but the choice between buprenorphine and clonidine should prioritize buprenorphine whenever possible 1. Clonidine functions as a second-line symptomatic treatment that addresses adrenergic symptoms but does not provide the mortality benefit associated with opioid agonist therapy 5.

All patients treated for withdrawal should receive naloxone for overdose reversal and referral to ongoing medication for opioid use disorder (MOUD) treatment 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.